Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 27, 2021
Patent Application Number
16083825
Date Filed
March 9, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is directed to ILT7 binding molecules, e.g., anti-ILT7 antibodies, and methods for treating or preventing conditions and diseases associated with ILT7-expressing cells such as autoimmune diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.